Impaired Negative Selection of T Cells in Hodgkin's Disease Antigen CD30-Deficient Mice

Cell

Volumn 84, Issue 4, 1996, Pages 551-562

  Amakawa, Ryuichi ^a   Hakem, Anne ^a   Kundig, Thomas M ^a   Matsuyama, Toshifumi ^a   Simard, John J L ^a   Timms, Emma ^a   Wakeham, Andrew ^a   Mittruecker, Hans Willi ^a   Griesser, Henrik ^a   Takimoto, Hiroaki ^a   Schmits, Rudolf ^a   Shahinian, Arda ^a   Ohashi, Pamela S ^a   Penninger, Josef M ^a   Mak, Tak W ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD30 ANTIGEN; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; T LYMPHOCYTE RECEPTOR GAMMA CHAIN; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CELL DEATH; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HODGKIN DISEASE; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T CELL LEUKEMIA VIRUS; MOUSE; NONHODGKIN LYMPHOMA; NONHUMAN; PRIORITY JOURNAL; REED STERNBERG CELL; T LYMPHOCYTE; THYMUS; TRANSGENIC MOUSE;

EID: 13244300652     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)81031-4     Document Type: Article

References (74)

1. Allen, R.C., Armitage, R.J., Conley, M.E., Rosenblatt, H., Jenkins, N.A., Copeland, N.G., Bedell, M.A., Edelhoff, S., Disteche, C.M., Simoneaux, D.K., Fanslow, W.C., Belmont, J., and Spriggs, M.K. (1993). CD40 ligand gene defects responsible for X-linked hyperIgM syndrome. Science 259, 990-993.
2. Alzona, M., Jaeck, H.M., Fisher, R.I., and Ellis, T.M. (1994). CD30 defines a subset of activated human T cells that produce IFN-γ and IL-5 and exhibit enhanced B cell helper activity. J. Immunol. 153, 2861-2867.
3. Andreesen, R., Osterholz, J., Loehr, G.W., and Bross, K.J. (1984). A Hodgkin cell-specific antigen is expressed on a subset of auto- and alloactivated T (helper) lymphoblasts. Blood 63, 1299-1302.
4. Aruffo, A., Farrington, M., Hollenbaugh, D., Li, X., Milatovich, A., Nonoyama, S., Bajorath, J., Grosmaire, L.S., Stenkamp, R., Neubauer, M., Roberts, R.L., Noelle, R.J., Ledbetter, J.A., Francke, U., and Ochs, H.D. (1993). The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell 72, 291-300.
5. Bachmann, M.F., and Kundig, T.M. (1994). In vivo versus in vitro assays for assessment of T- and B-cell function. Curr. Opin. Immunol. 6, 320-326.
6. + T cells correlating with cytotoxic activity in vitro are more efficient in antivaccinia virus protection than CD4-dependent IL. J. Immunol. 146, 4301-4307.
7. - T lymphocytes. J. Exp. Med. 168, 1899-1916.
8. Bradley, A., Evans, M., Kaufman, M.H., and Robertson, E. (1984). Formation of germ-linechimaeras from embryo-derived teratocarcinoma cell lines. Nature 309, 255-256.
9. Caligariscappio, F., Bertero, M.T., Converso, M., Stacchini, A., Vinante, F., Romagnani, S., and Pizzolo, G. (1995). Circulating levels of soluble CD30, a marker of cells producing TH2-type cytokines, are increased in patients with systemic lupus-erythematosus and correlate with disease activity. Clin. Exp. Rheumatol. 13, 339-343.
10. Clement, M.V., and Stamenkovic, I. (1994). Fas and tumor-necrosis-factor receptor-mediated cell-death: similarities and distinctions. J. Exp. Med. 180, 557-567.
11. Cleveland, J.L., and Ihle, J.N. (1995). Contenders in FasL/TNF death signaling. Cell 81, 479-482.
12. + T cells producing Th2-type cytokines. FASEB J. 9, 81-86.
13. Dent, A.L., Matis, L.A., Hooshmand, F., Widacki, S.M., Bluestone, J.A., and Hedrick, S.M. (1990). Self-reactive γδ T cells are eliminated in the thymus. Nature 343, 714-719.
14. DiSanto, J.P., Bonnefoy, J.Y., Gauchat, J.F., Fischer, A., and de Saint Basile, G. (1993). CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM. Nature 361, 541-543.
15. Dürkop, H., Latza, U., Hummel, M., Eitelbach, F., Seed, B., and Stein, H. (1992). Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease. Cell 68, 421-427.
16. + T cells. J. Immunol. 151, 2380-2389.
17. Erickson, S.L., de Sauvage, F.J., Kikly, K., Carver-Moore, K., Pitts-Meek, S., Gillett, N., Sheehan, K.C., Schreiber, R.D., Goeddel, D.V., and Moore, M.W. (1994). Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice. Nature 372, 560-563.
18. Fonatsch, C., Latza, U., Dürkop, H., Rieder, H., and Stein, H. (1992). Assignment of the human CD30 (Ki-1) gene to 1p36. Genomics 14, 825-826.
19. Fowlkes, B.J., and Pardoll, D.M. (1989). Molecular and cellular events of T cell development. Adv. Immunol. 44, 207-264.
20. Foy, T.M., Page, D.M., Waldschmidt, T.J., Schoneveld, A., Laman, J.D., Masters, S.R., Tygrett, L., Ledbetter, J.A., Aruffo, A., Classen, E., Xu, J.C., Flavell, R.A., Oehen, S., Hedrick, S.M., and Noelle, R.J. (1995). An essential role for gp39, the ligand for CD40, in thymic selection. J. Exp. Med. 182, 1377-1388.
21. Froese, P., Lemke, H., Gerdes, J., Havsteen, B., Schwarting, R., Hansen, H., and Stein, H. (1987). Biochemical characterization and biosynthesis of the Ki-1 antigen in Hodgkin-derived and virus-transformed human B and T lymphoid cell lines. J. Immunol. 139, 2081-2087.
22. Fung-Leung, W.-P., Schilham, M.W., Rahemtulla, A., Kündig, T.M., Vollenweider, M., Potter, J., van Ewijk, W., and Mak, T.W. (1991). CD8 is needed for development of cytotoxic T cells but not helper T cells. Cell 65, 443-449.
23. Gause, A., Pohl, C., Tschiersch, A., Costa, L.D., Jung, W., Diehl, V., Hasenclever, D., and Pfreundschuh, M. (1991). Clinical significance of soluble CD30 antigen in the sera of patients with untreated Hodgkin's disease. Blood 77, 1983-1988.
24. Gribskov, M., McLachlan, A.D., and Eisenberg, D. (1987). Profile analysis: detection of distantly related proteins. Proc. Natl. Acad. Sci. USA 84, 4355-4358.
25. Gruss, H.J., Boiani, N., Williams, D.E., Armitage, R.J., Smith, C.A., and Goodwin, R.G. (1994). Pleiotropic effects of the CD30 ligand on CD30-expressing cells and lymphoma cell lines. Blood 83, 2045-2056.
26. Kemper, O., Derre, J., Cherif, D., Engelmann, H., Wallach, D., and Berger, R. (1991). The gene for the type II (p75) tumor necrosis factor receptor (TNF-RII) is localized on band 1p36.2-p36.3. Hum. Genet. 87, 623-624.
27. Korthauer, U., Graf, D., Mages, H.W., Briere, F., Padayachee, M., Malcolm, S., Ugazio, A.G., Notarangelo, L.D., Levinsky, R.J., and Kroczek, R.A. (1993). Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature 361, 539-541.
28. Kundig, T.M., Bachmann, M.F., Lefrancois, L., Puddington, L., Hengartner, H., and Zinkernagel, R.M. (1993a). Nonimmunogenic tumor cells may efficiently restimulate tumor antigen-specific cytotoxic T cells. J. Immunol. 150, 4450-4456.
29. Kundig, T.M., Castelmur, I., Bachmann, M.F., Abraham, D., Binder, D., Hengartner, H., and Zinkernagel, R.M. (1993b). Fewer protective cytotoxic T-cell epitopes than T-helper-cell epitopes on vesicular stomatitis virus. J. Virol. 67, 3680-3683.
30. Latza, U., Dürkop, H., Schnittger, S., Ringeling, J., Eitelbach, F., Hummel, M., Fonatsch, C., and Stein, H. (1994). The human OX40 homolog: cDNA structure, expression and chromosomal assignment of the ACT35 antigen. Eur. J. Immunol. 24, 677-683.
31. Lynch, D.H., Watson, M.L., Alderson, M.R., Baum, P.R., Miller, R.E., Tough, T., Gibson, M., Davis-Smith, T., Smith, C.A., Hunter, K., Bhat, D., Din, W., Goodwin, R.G., and Seldin, M.F. (1994). The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster. Immunity 1, 131-136.
32. + T cells showing B cell helper function and reduced cytolytic activity in human immunodeficiency virus type 1 infection. J. Exp. Med. 180, 489-495.
33. + T cell clones in human immunodeficiency virus infection. J. Exp. Med. 180, 2407-2411.
34. McDonald, P.P., Cassatella, M.A., Bald, A., Maggi, E., Romagnani, S., Gruss, H.J., and Pizzolo, G. (1985). CD30 ligation induces nuclear factor-κB activation in human T-cell lines. Eur. J. Immunol. 25, 2870-2876.
35. Mechtersheimer, G., and Moller, P. (1990). Expression of Ki-1 antigen (CD30) in mesenchymal tumors. Cancer 66, 1732-1737.
36. P selectively express CD45RO (UCHL1). Int. Immunol. 1, 450-459.
37. Nawrocki, J.F., Kirsten, E.S., and Fisher, R.I. (1988). Biochemical and structural properties of a Hodgkin's disease-related membrane protein. J. Immunol. 141, 672-680.
38. Pallesen, G. (1990). The diagnostic significance of the CD30 (Ki-1) antigen. Histopathology 16, 409-413.
39. Pallesen, G., and Hamilton-Dutoit, S.J. (1988). Ki-1 (CD30) antigen is regularly expressed by tumor cells of embryonal carcinoma. Am. J. Pathol. 133, 446-450.
40. Pfeffer, K., Matsuyama, T., Kündig, T.M., Wakeham, A., Kishihara, K., Shahinian, A., Wiegmann, K., Ohashi, P.S., Krönke, M., and Mak, T.W. (1993). Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73, 457-467.
41. Piris, M., Brown, D.C., Gatter, K.C., and Mason, D.Y. (1990). CD30 expression in non-Hodgkin's lymphoma. Histopathology 17, 211-218.
42. Pizzolo, G., Vinante, F., Chilosi, M., Dallenbach, F., Alasevic, O.J., Diamantstein, T., and Stein, H. (1990). Serum levels of soluble CD30 molecule (Ki-1 antigen) in Hodgkin's disease: relationship with disease activity and clinical stage. Br. J. Haematol. 75, 282-284.
43. Pizzolo, G., Vinante, F., Morosato, L., Nadali, G., Chilosi, M., Gandini, G., Sinicco, A., Raiteri, R., Semenzato, G., Stein, H., and Perona, G. (1994). High serum level of the soluble form of CD30 molecule in the early phase of HIV-1 infection as an independent predictor of progression to AIDS. AIDS 8, 741-745.
44. Puddington, L., Bevan, M.J., Rose, J.K., and Lefrancois, L. (1986). N protein is the predominant antigen recognized by vesicular stomatitis virus-specific cytotoxic T cells. J. Virol. 60, 708-717.
45. Ramsdell, F., and Fowlkes, B.J. (1990). Clonal deletion versus clonal anergy: the role of the thymus in inducing self tolerance. Science 248, 1342-1348.
46. Robey, E., and Fowlkes, B.J. (1994). Selective events in T cell development. Annu. Rev. Immunol. 12, 675-705.
47. Rothe, J., Lesslauer, W., Lotscher, H., Lang, Y., Koebel, P., Kontgen, F., Althage, A., Zinkernagel, R., Steinmetz, M., and Bluethmann, H. (1993). Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364, 798-802.
48. Schuurman, H.J., van Wichen, D., and de Weger, R.A. (1989). Expression of activation antigens on thymocytes in the 'common thymocyte' stage of differentiation. Thymus 14, 43-53.
49. Schwab, U., Stein, H., Gerdes, J., Lemke, H., Kirchner, H., Schaadt, M., and Diehl, V. (1982). Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells. Nature 299, 65-67.
50. Schwarting, R., Gerdes, J., Dürkop, H., Falini, B., Pileri, S., and Stein, H. (1989). BER-H2: a new anti-Ki-1 (CD30) monoclonal antibody directed at a formol-resistant epitope. Blood 74, 1678-1689.
51. Schwartz, R.H. (1989). Acquisition of immunologic self-tolerance. Cell 57, 1073-1081.
52. Scollay, R., Bartlett, P., and Shortman, K. (1984). T cell development in the adult murine thymus: changes in the expression of the surface antigens Ly2, L3T4 and B2A2 during development from early precursor cells to emigrants. Immunol. Rev. 82, 79-103.
53. Sellins, K.S., and Cohen, J.J. (1987). Gene induction by γ-irradiation leads to DNA fragmentation in lymphocytes. J. Immunol. 139, 3199-3206.
54. Shi, Y.F., Bissonnette, R.P., Parfrey, N., Szalay, M., Kubo, R.T., and Green, D.R. (1991). In vivo administration of monoclonal antibodies to the CD3 T cell receptor complex induces cell death (apoptosis) in immature thymocytes. J. Immunol. 146, 3340-3346.
55. Singer, G.G., and Abbas, A.K. (1994). The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1, 365-371.
56. Skeen, M.J., and Ziegler, H.K. (1993). Induction of murine peritoneal γ/δ T cells and their role in resistance to bacterial infection. J. Exp. Med. 178, 971-984.
57. Smith, C.A., Williams, G.T., Kingston, R., Jenkinson, E.J., and Owen, J.J. (1989). Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature 337, 181-184.
58. Smith, C.A., Gruss, H.-J., Davis, T., Anderson, D., Farrah, T., Baker, E., Sutherland, G.R., Brannan, C.I., Copeland, N.G., Jenkins, N.A., Grabstein, K.H., Gliniak, B., McAlister, I.B., Fanslow, W., Alderson, M., Falk, B., Gimpel, S., Gillis, S., Din, W.S., Goodwin, R.G., and Armitage, R.J. (1993). CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell 73, 1349-1360.
59. Sprent, J., and Webb, S.R. (1995). Intrathymic and extrathymic clonal deletion of T-cells. Curr. Opin. Immunol. 7, 196-205.
60. Sprent, J., Lo, D., Gao, E.K., and Ron, Y. (1988). T cell selection in the thymus. Immunol. Rev. 101, 173-190.
61. Stein, H., Gerdes, J., Schwab, U., Lemke, H., Mason, D.Y., Ziegler, A., Schienle, W., and Diehl, V. (1982). Identification of Hodgkin and Sternberg-Reed cells as a unique cell type derived from a newly-detected small-cell population. Int. J. Cancer 30, 445-459.
62. Stein, H., Mason, D.Y., Gerdes, J., O'Connor, N., Wainscoat, J., Pallesen, G., Gatter, K., Falini, B., Delsol, G., Lemke, H., Schwarting, R., and Lennert, K. (1985). The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 66, 848-858.
63. Suchi, T., Lennert, K., Tu, L.Y., Kikuchi, M., Sato, E., Stansfeld, A.G., and Feller, A.C. (1987). Histopathology and immunohistochemistry of peripheral T cell lymphomas: a proposal for their classification. J. Clin. Pathol. 40, 995-1015.
64. Surh, C.D., and Sprent, J. (1994). T-cell apoptosis detected in situ during positive and negative selection in the thymus. Nature 372, 100-103.
65. Takahashi, T., Tanaka, M., Brannan, C.I., Jenkins, N.A., Copeland, N.G., Suda, T., and Nagata, S. (1994). Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76, 969-976.
66. Tatsumi, Y., Pena, J.C., Matis, L., DeLuca, D., and Bluestone, J.A. (1993). Development of T cell receptor-γδ cells: phenotypic and functional correlations of T cell receptor-γδ thymocyte maturation. J. Immunol. 151, 3030-3041.
67. Teh, H.S., Kisielow, P., Scott, B., Kishi, H., Uematsu, Y., Bluthmann, H., and von Boehmer, H. (1988). Thymic major histocompatibility complex antigens and the αβ T-cell receptor determine the CD4/ CD8 phenotype of T cells. Nature 335, 229-233.
68. Thomas, K.R., and Capecchi, M.R. (1987). Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell 51, 503-512.
69. Thompson, S., Clarke, A.R., Pow, A.M., Hooper, M.L., and Melton, D.W. (1989). Germ line transmission and expression of a corrected HPRT gene produced by gene targeting in embryonic stem cells. Cell 56, 313-321.
70. von Boehmer, H. (1990). Developmental biology of T cells in T cell-receptor transgenic mice. Annu. Rev. Immunol. 8, 531-556.
71. high expression induced by thymic selection events. J. Exp. Med. 176, 1657-1663.
72. Watanabe-Fukunaga, R., Brannan, C.I., Copeland, N.G., Jenkins, N.A., and Nagata, S. (1992). Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356, 314-317.
73. Wyllie, A.M. (1980). Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284, 555-556.
74. Zheng, L.X., Fisher, G., Miller, R.E, Peschon, J., Lynch, D.H. and Lenardo, M.J. (1995). Induction of apoptosis in mature T cells by tumor necrosis factor. Nature 377, 348-351.